Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Lin Kang, Shilin Jin, Jiayi Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 458-473
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
Shaza S. Issa, Alisa A. Shaimardanova, Valeriya V. Solovyeva, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 785-785
Open Access | Times Cited: 147
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access | Times Cited: 2
A Comprehensive Review of Emerging Trends and Innovative Therapies in Epilepsy Management
Shampa Ghosh, Jitendra Kumar Sinha, Soumya K. Ghosh, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1305-1305
Open Access | Times Cited: 38
Myricetin Oligomer Triggers Multi-Receptor Mediated Penetration and Autophagic Restoration of Blood-Brain Barrier for Ischemic Stroke Treatment
Lei Liu, Zhifang Ma, Qiaoyi Han, et al.
ACS Nano (2024) Vol. 18, Iss. 14, pp. 9895-9916
Closed Access | Times Cited: 12
Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications
Dezhuang Ye, Chinwendu Chukwu, Yaoheng Yang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115363-115363
Open Access | Times Cited: 10
Recombinant Adeno-Associated Virus Vectors for Gene Therapy of the Central Nervous System: Delivery Routes and Clinical Aspects
Żaneta Słyk, Natalia Stachowiak, Maciej Małecki
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1523-1523
Open Access | Times Cited: 10
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 10
Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation
Na Kyung Lee, Jong Wook Chang
Annals of Laboratory Medicine (2024) Vol. 44, Iss. 4, pp. 314-323
Open Access | Times Cited: 9
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
Yuge Xu, Xue Bai, Jianhua Lin, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101420-101420
Open Access | Times Cited: 1
The translational potential of cholesterol-based therapies for neurological disease
Marta Valenza, Giulia Birolini, Elena Cattaneo
Nature Reviews Neurology (2023) Vol. 19, Iss. 10, pp. 583-598
Closed Access | Times Cited: 19
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome
Yi Chen, Guiquan Wang, Jingqiao Chen, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 4, pp. 437-459
Open Access | Times Cited: 6
Highly conserved brain vascular receptor ALPL mediates transport of engineered viral vectors across the blood-brain barrier
Tyler C. Moyer, Brett Hoffman, Weitong Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Strategies for enhanced gene delivery to the central nervous system
Zhenghong Gao
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3009-3028
Open Access | Times Cited: 6
Drug product formulation and fill/finish manufacturing process considerations for AAV-based genomic medicines
Madhura Som, Benson Gikanga, Varna Kanapuram, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 7, pp. 1711-1725
Closed Access | Times Cited: 5
Therapeutic prime/pull vaccination of HSV-2-infected guinea pigs with the ribonucleotide reductase 2 (RR2) protein and CXCL11 chemokine boosts antiviral local tissue-resident and effector memory CD4 + and CD8 + T cells and protects against recurrent genital herpes
Afshana Quadiri, Swayam Prakash, Nisha R. Dhanushkodi, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Open Access | Times Cited: 5
RNA nanotherapeutics for hepatocellular carcinoma treatment
Yihang Yuan, Weijie Sun, Jiaqi Xie, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 965-992
Closed Access | Times Cited: 5
Separation of full and empty adeno-associated virus capsids by anion-exchange chromatography using choline-type salts
Sam Kurth, Tianyu Li, Alana Hausker, et al.
Analytical Biochemistry (2023) Vol. 686, pp. 115421-115421
Open Access | Times Cited: 13
Challenges in Permeability Assessment for Oral Drug Product Development
Mirko Koziolek, Patrick Augustijns, Constantin Berger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 11
Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects
Kuldeep Singh, Bharat Bhushan, Sunil Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 5, pp. 377-394
Closed Access | Times Cited: 4
Structural basis of the recognition of adeno-associated virus by the neurological system-related receptor carbonic anhydrase IV
Ran Zhang, Yixiao Liu, Fengxi Yu, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 2, pp. e1011953-e1011953
Open Access | Times Cited: 4
AAV-mediated gene therapy for sialidosis
Diantha van de Vlekkert, Huimin Hu, Jason A. Weesner, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2094-2112
Open Access | Times Cited: 4
Serotype-agnostic affinity purification of adeno-associated virus (AAV) via peptide-functionalized chromatographic resins
Shriarjun Shastry, Eduardo Barbieri, Arianna Minzoni, et al.
Journal of Chromatography A (2024) Vol. 1734, pp. 465320-465320
Closed Access | Times Cited: 4
Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system
A. Carneiro, David V. Schaffer
Current Opinion in Chemical Biology (2024) Vol. 83, pp. 102532-102532
Closed Access | Times Cited: 4
Engineered virus-like particle-assembled VEGF-targeting Cas9 ribonucleoprotein treatment alleviates neovascularization in wet age-related macular degeneration
Jun Wu, Hyewon Jang, Hyunjong Kwak, et al.
Research Square (Research Square) (2025)
Closed Access
A comprehensive analysis of scRNA-Seq and RNA-Seq unveils B cell immune suppression in the AAV-loaded brain
Shunyu Wu, Xue Lü, Xiang Li, et al.
Immunologic Research (2025) Vol. 73, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top